pertagen Dosage/Direction for Use

Posology: A single 0.5 mL dose of Pertagen is recommended.
Pertagen should be given in accordance with WHO and national recommendations or medical practices for booster vaccination and for maternal immunization in the second and third trimester preferably at least 15 days before the end of pregnancy, for protection of infants against pertussis.
Pertagen may be considered as an alternative to acellular pertussis combinations (DTaP or Tdap-based vaccines) for pertussis booster immunization in subjects with known hypersensitivity to tetanus (Arthus-type hypersensitivity reaction) or diphtheria vaccines and in individuals who have received multiple and frequent tetanus or diphtheria vaccine doses.
Administration: Pertagen should be administered by deep intramuscular injection, preferably in the deltoid region. The skin over the site of injection should be cleaned before injection. Shake well before use. Do not use if resuspension does not occur after vigorous shaking. Open the needle cap of the pre-filled syringe, administer the total volume of 0.5 mL intramuscularly (IM).